Central Glass (4044) · PolicyAchieved
Application of the revenue recognition and fair value measurement standards from the fiscal year ending March 2022
First written in FY2021. 1 of 2 entries say "Achieved", first in FY2022-Q1. Latest entry: FY2022-Q1.
2entries
1years
0from disclosures
How it moved
Same theme, other companies
Simultaneous application of the Revenue Recognition and Fair Value Measurement Accounting StandardsA theme 199 companies write about · 7 as a headwind · 2 as a tailwind
36 other companies' latest entry also says "Achieved".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 199 companies compared. The sentences above are computed from all 199.Full recordFilings, disclosures and news, newest first
- FY2022-Q1AchievedAnnual report
「The company applied the Accounting Standard for Revenue Recognition (ASBJ Statement No. 29, 31 March 2020) and related standards from the beginning of the first quarter of the current fiscal year. Revenue is recognized at the amount expected to be received in exchange for the promised goods or services when control of those goods or services transfers to the customer.」
The revenue recognition accounting standard, which had been scheduled for application from the fiscal year ending March 2022, was applied from the beginning of the first quarter. As a result, net sales decreased by ¥581 million and operating profit and other items decreased by ¥14 million. - FY2021First statedAnnual report
「We will apply the standard from the beginning of the fiscal year ending March 2022.」
The company planned to apply the accounting standards for revenue recognition and fair value measurement from the beginning of the fiscal year ending March 2022. It stated that the impact of the revenue recognition standard would be immaterial and that the fair value measurement standard would have no impact.